Figure 2.

Comparisons of cumulative incidence of all-cause mortality between the study groups. The cumulative incidence comparing the time to all-cause mortality between the study groups. The multivariate adjusted survival curves of the ACEI/ARB (a) and CCB (b) groups show a lower trend of all-cause mortality compared to the comparison group. The CCB and ACEI/ARB groups have similar all-cause mortality throughout the follow-up period (c).

ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel blocker.